REGULUS THERAPEUTICS INC's ticker is RGLS and the CUSIP is 75915K200. A total of 1 filers reported holding REGULUS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $36,000 | +157.1% | 70,204 | +241.2% | 0.00% | +200.0% |
| Q2 2020 | $14,000 | +40.0% | 20,575 | -0.8% | 0.00% | 0.0% |
| Q1 2020 | $10,000 | -47.4% | 20,741 | -0.6% | 0.00% | -50.0% |
| Q4 2019 | $19,000 | -36.7% | 20,864 | -49.3% | 0.00% | -33.3% |
| Q3 2019 | $30,000 | -28.6% | 41,167 | +23.3% | 0.00% | -25.0% |
| Q2 2019 | $42,000 | -4.5% | 33,376 | -23.3% | 0.00% | -20.0% |
| Q1 2019 | $44,000 | +46.7% | 43,489 | +32.8% | 0.01% | +25.0% |
| Q4 2018 | $30,000 | – | 32,738 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 1,985,472 | $3,097,000 | 1.60% |
| Endurant Capital Management LP | 2,376,557 | $3,707,000 | 0.97% |
| Sarissa Capital Management LP | 1,851,851 | $2,888,000 | 0.28% |
| NEA Management Company, LLC | 6,451,056 | $10,064,000 | 0.23% |
| Atom Investors LP | 337,228 | $526,000 | 0.09% |
| Ikarian Capital, LLC | 1,245,989 | $1,943,000 | 0.06% |
| GYL FINANCIAL SYNERGIES, LLC | 51,376 | $80,000 | 0.04% |
| Focused Wealth Management, Inc | 100,000 | $156,000 | 0.03% |
| Point72 Asset Management, L.P. | 3,215,436 | $5,016,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 141,629 | $221,000 | 0.01% |